Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Conran

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Expert Opinion on Investigational Drugs|February 17, 2015
Prospects for early investigational therapies for sickle cell diseaseNicola Conran
Acta Haematologica|February 15, 2014
Intravascular hemolysis: a disease mechanism not to be ignoredNicola Conran
Ebiomedicine|July 3, 2015
High Foetal Haemoglobin in Sickle Cell Disease: Not so Protective?Nicola Conran
Haematologica|May 26, 2022
Pain mechanisms in sickle cell disease. Are we closer to a breakthrough?Nicola Conran
Experimental Biology and Medicine (Maywood, N.J.)|January 30, 2019
cGMP modulation therapeutics for sickle cell diseaseNicola Conran, Lidiane Torres
Expert Opinion on Pharmacotherapy|December 1, 2018
Emerging pharmacotherapeutic approaches for the management of sickle cell diseaseLidiane Torres, Nicola Conran
Experimental Biology and Medicine (Maywood, N.J.)|April 2, 2021
Sickle cell vaso-occlusion: The dialectic between red cells and white cellsNicola Conran, Stephen H Embury
Function (Oxford, England)|September 26, 2022
Sickle Cell Disease and Oxidative Stress: Implications for a Role of Diminished Endothelial SOD2 in Pulmonary ComplicationsNicola Conran, Fernando F Costa
Expert Opinion on Investigational Drugs|June 1, 2017
Prasugrel hydrochloride for the treatment of sickle cell diseaseNicola Conran, David C Rees
Revista Brasileira De Hematologia E Hemoterapia|March 13, 2016
Hemolytic vascular inflammation: an updateNicola Conran, Camila Bononi Almeida
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Expert Opinion on Investigational Drugs|February 17, 2015
Prospects for early investigational therapies for sickle cell diseaseNicola Conran
Acta Haematologica|February 15, 2014
Intravascular hemolysis: a disease mechanism not to be ignoredNicola Conran
Ebiomedicine|July 3, 2015
High Foetal Haemoglobin in Sickle Cell Disease: Not so Protective?Nicola Conran
Haematologica|May 26, 2022
Pain mechanisms in sickle cell disease. Are we closer to a breakthrough?Nicola Conran
Experimental Biology and Medicine (Maywood, N.J.)|January 30, 2019
cGMP modulation therapeutics for sickle cell diseaseNicola Conran, Lidiane Torres
Expert Opinion on Pharmacotherapy|December 1, 2018
Emerging pharmacotherapeutic approaches for the management of sickle cell diseaseLidiane Torres, Nicola Conran
Experimental Biology and Medicine (Maywood, N.J.)|April 2, 2021
Sickle cell vaso-occlusion: The dialectic between red cells and white cellsNicola Conran, Stephen H Embury
Function (Oxford, England)|September 26, 2022
Sickle Cell Disease and Oxidative Stress: Implications for a Role of Diminished Endothelial SOD2 in Pulmonary ComplicationsNicola Conran, Fernando F Costa
Expert Opinion on Investigational Drugs|June 1, 2017
Prasugrel hydrochloride for the treatment of sickle cell diseaseNicola Conran, David C Rees
Revista Brasileira De Hematologia E Hemoterapia|March 13, 2016
Hemolytic vascular inflammation: an updateNicola Conran, Camila Bononi Almeida
Pageof 9